Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Thorax

• Publication date

  1988-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.43.9.715PMID 3194878PMCID PMC461461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.

  1987cited by this paper
• Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.

  1987cited by this paper
• Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.

  1987cited by this paper
• Penetration of ciprofloxacin into gynecologic tissues.

  1987cited by this paper
• Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure.

  1987cited by this paper
• Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody.

  1987cited by this paper
• Penetration of enoxacin into human bronchial mucosa.

  1986cited by this paper
• Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin.

  1986cited by this paper
• The comparative in-vitro activity of eight newer quinolones and nalidixic acid.

  1986cited by this paper
• Penetration of cefaclor into bronchial mucosa.

  1984cited by this paper
• In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

  1983cited by this paper
• Penetration of piperacillin into bronchial mucosa and sputum.

  1981cited by this paper
• Penetration of antibiotics into the respiratory tree.

  1981cited by this paper
• Penetration of antibiotics into respiratory secretions.

  1981cited by this paper
• Serum and sputum levels of cefaclor.

  1979cited by this paper
• Distribution of Gentamicin and Amikacin in Rabbit Tissues

  1977cited by this paper
• Amoxycillin levels in sputum, serum, and saliva

  1974cited by this paper
• Influence of lipophilic character on the antibacterial activity of cephalosporins and penicillins.

  1970cited by this paper
• Ampicillin levels in sputum, serum, and saliva.

  1970cited by this paper
• The mucosal epithelium of the respiratory tract in muco-purulent bronchitis caused by Haemophilus influenzae.

  1953cited by this paper

• Management Strategies for Chronic Suppurative Otitis Media and Why They Fail

  2025cites this paper
• DETERMINATION OF AMOXICILLIN AND COTRIMOXAZOLE CONCENTRATIONS IN SPUTUM OF PATIENTS WITH CYSTIC FIBROSIS.

  2021cites this paper
• Low penetrance of antibiotics in the epithelial lining fluid. Experience from the use of inhaled antibiotics in patients with non CF-bronchiectasis.

  2019cites this paper
• Highly Sensitive Broadband Raman Sensing of Antibiotics in Step-Index Hollow-Core Photonic Crystal Fibers

  2017cites this paper
• Update on a proper use of systemic fluoroquinolones in adult patients (ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, pefloxacin. SPILF.).

  2015cites this paper
• Activities of Ciprofloxacin and Sparfloxacin against Streptococcus pneumoniae

  2012cites this paper
• Influence of a pig respiratory disease on the pharmacokinetic behaviour of amoxicillin after oral ad libitum administration in medicated feed.

  2011influential citation
• Challenges in inhaled product development and opportunities for open innovation.

  2011cites this paper
• Antimicrobial chemotherapy and lung microdialysis: a review.

  2010cites this paper
• Does ciprofloxacin have an obverse and a reverse?

  2010cites this paper
• Ciprofloxacin Penetration into the Pulmonary Parenchyma in Japanese Patients

  2007cites this paper
• Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line.

  2007cites this paper
• [Blood and respiratory diffusion of antibiotics. A critical analysis of predictive parameters for clinical effectiveness].

  2006cites this paper
• PENETRATION OF CIPROFLOXACIN INTO PULMONARY PARENCHYMA IN JAPANESE PATIENTS

  2006cites this paper
• 05 -Diffusion sérique et respiratoire des antibiotiques. analyse critique des paramètres prédictifs d'efficacité clinique

  2006cites this paper
• Antimicrobial Treatment of Ventilator-Associated Pneumonia

  2005cites this paper
• Contribution of Immunocompetence to the Antibacterial Activities of Ciprofloxacin and Moxifloxacin in an in Vitro Pharmacodynamic Model*

  2005influential citation
• Pharmacokinetics and Pharmacodynamics in Pleural Fluid

  2004cites this paper
• Antibiotic penetration into lung tissues

  2004cites this paper
• The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration

  2004cites this paper
• Antibiotic penetration into lung tissues

  2004cites this paper
• Management of the Undiagnosed Persistent Pleural Effusion

  2004cites this paper
• Penetration of Meropenem into Pneumonic Human Lung Tissue as Measured by In Vivo Microdialysis

  2004cites this paper
• Antibiotic penetration into lung tissues

  2004cites this paper
• Antibiotic penetration into lung tissues

  2004cites this paper
• Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.

  2003cites this paper
• Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects.

  2003cites this paper
• Comparative Bactericidal Activity of Fluoroquinolones Against Clinical Isolates Resistant to Fluoroquinolones

  2003cites this paper
• Intrapulmonary Pharmacokinetics of Antibacterial Agents

  2002cites this paper
• Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.

  2002cites this paper
• [Pulmonary diffusion of antibiotics. Critical analysis of the literature].

  2001cites this paper
• Pharmacokinetic population study to describe cefepime lung concentrations.

  2001cites this paper
• Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.

  2001cites this paper
• Diffusion pulmonaire des antibiotiques.Analyse critique de la littérature

  2001cites this paper
• PRODUCT MONOGRAPH

  2000cites this paper
• Assessment of the drug level in bronchial secretion with patient's noncompliance and oral dosage forms with controlled release

  2000cites this paper
• Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.

  1999cites this paper
• Trovafloxacin: An Overview

  1999cites this paper
• The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy.

  1999cites this paper
• Therapeutic Effect of Oral Levofloxacin, Ciprofloxacin, and Ampicillin on Experimental Murine Pneumonia Caused by Penicillin Intermediate Streptococcus pneumoniae for Which the Minimum Inhibitory Concentrations of the Quinolones Are Similar

  1999cites this paper
• Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.

  1999cites this paper
• Intrapulmonary concentrations of antimicrobial agents.

  1998cites this paper
• Penetration of Levofloxacin into Lung Tissue after Oral Administration to Subjects Undergoing Lung Biopsy or Lobectomy

  1998cites this paper
• Penetration of amoxycillin into the respiratory tract tissues and secretions in pigs.

  1998cites this paper
• Calculation of the antibiotic level in the lung tissue and bronchial secretion with an oral controlled-release dosage form

  1998cites this paper
• Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.

  1997cites this paper
• Pharmacokinetics of grepafloxacin.

  1997cites this paper
• The penetration of novel intravenous cephalosporins into the lung.

  1996cites this paper
• Pharmacokinetics of antimicrobial agents in the respiratory tract.

  1996cites this paper
• Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong.

  1996cites this paper
• Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.

  1995cites this paper
• 5-Day Rufloxacin Treatment Versus 7-Day Ciprofloxacin Treatment in Patients with Acute Exacerbations of Chronic Bronchitis

  1995cites this paper
• Co-amoxiclav levels in bronchial mucosa.

  1995cites this paper
• AUTHORS' REPLY

  1995cites this paper
• Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens.

  1994cites this paper
• Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis.

  1994cites this paper
• Antibiotic penetration into lung tissues.

  1994cites this paper
• The concentration of sparfloxacin in lung tissues after single and multiple oral doses.

  1994cites this paper
• Concentration of amoxycillin and clavulanate in lung compartments in adults without pulmonary infection.

  1994cites this paper
• Ciprofloxacin in respiratory tract infections: A phase IV surveillance study

  1994cites this paper
• Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.

  1993cites this paper
• Penetration of danofloxacin into the respiratory tract tissues and secretions in calves.

  1993cites this paper
• Tissue distribution of dirithromycin: comparison with erythromycin.

  1993cites this paper
• Pulmonary disposition of antimicrobial agents: methodological considerations

  1992cites this paper
• The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.

  1992cites this paper
• Bronchoalveolar distribution of cefuroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens.

  1992cites this paper
• The site concentrations of antimicrobial agents in the lung.

  1992cites this paper
• Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.

  1992cites this paper
• Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.

  1992cites this paper
• MINIREVIEWS Pulmonary Disposition ofAntimicrobial Agents: Methodological Considerations

  1992cites this paper
• Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance

  1992cites this paper
• Quantitative morphology and water distribution of bronchial biopsy samples.

  1992cites this paper
• Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin.

  1991cites this paper
• The penetration of cefpirome into the potential sites of pulmonary infection.

  1991cites this paper
• The role of temafloxacin in the community setting: an overview.

  1991cites this paper
• Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study.

  1991cites this paper
• Nosocomial Pneumonia

  1991cites this paper
• Pleural penetration of ciprofloxacin in patients with empyema thoracis.

  1991cites this paper
• Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.

  1991cites this paper
• Oral antibiotics for pneumonia.

  1991cites this paper
• Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice

  1991cites this paper
• The Assay of New Antimicrobials and the Penetration of Drugs into Tissues

  1991cites this paper
• Antimicrobial Treatment of Respiratory Tract Infections

  1991cites this paper
• Reproducibility of the measurement of ciprofloxacin concentration in bronchial mucosa.

  1991cites this paper
• Concentrations of temafloxacin in serum and bronchial mucosa

  1990cites this paper
• Concentrations of oral lomefloxacin in serum and bronchial mucosa

  1990cites this paper
• Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose.

  1990cites this paper
• Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens.

  1990cites this paper
• Extravascular penetration of ciprofloxacin. A review.

  1990cites this paper
• Brief report: Respiratory tract penetration of ciprofloxacin

  1989cites this paper
• Respiratory tract penetration of ciprofloxacin.

  1989cites this paper
• Disc sensitivity testing with ciprofloxacin.

  1989cites this paper
• LETTERS TO THE EDITOR Co-amoxiclav

  year unknowncites this paper